Literature DB >> 31976626

Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.

Mohammad Hossein Anbardar1,2, Raha Monjazeb3.   

Abstract

BACKGROUND: Recently, The Paris System for Reporting Urinary Cytology (TPS) has led to major changes in the approach to evaluate urine cytology and pattern of reporting. The aim of this study was to reclassify urine cytology reports with TPS in order to determine the frequency of abnormal results compared with the previous system; also, we performed cytohistological correlation in abnormal cytological results.
METHODS: In this study, the voided urine specimens from the patients referred to Shiraz University of Medical Sciences affiliated laboratories were retrieved and analyzed using the laboratory's electronic records system; slides prepared from the samples were reviewed by single cytopathologist blindly according to the proposed criteria of TPS.
RESULTS: Totally, 1842 urine cytology slides from 828 patients were blindly evaluated by TPS criteria and compared with routine urine cytology classification. Then, available cytohistological correlation was done on 99 abnormal urine cytological results from 58 patients. Among the 26 cytology slides with atypical urothelial cell (AUC) in the previous classification, eight (30.70%) slides were downgraded to negative results, and four (15.30%) were upgraded to higher groups. Therefore, through the reclassification of the slides with TPS, 46% of the AUC changed to other groups. Diagnostic accuracy of the TPS classified urine cytology was 78%, including 87.88% sensitivity, 27.27% specificity, 64.44% positive predictive value, and 60% negative predictive value.
CONCLUSION: The findings of the present study confirmed the importance and utility of TPS regarding the reclassification of AUC to other groups and its high sensitivity for detecting high-grade urothelial carcinoma (HGUC).
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  The Paris System; high-grade urothelial carcinoma; sensitivity; urine cytology

Year:  2020        PMID: 31976626     DOI: 10.1002/dc.24387

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  5 in total

1.  Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study.

Authors:  Vittorio Fasulo; Marco Paciotti; Massimo Lazzeri; Roberto Contieri; Paolo Casale; Alberto Saita; Giovanni Lughezzani; Pietro Diana; Nicola Frego; Pier Paolo Avolio; Piergiuseppe Colombo; Grazia Maria Elefante; Giorgio Guazzoni; Nicolò Maria Buffi; Michael Bates; Rodolfo Hurle
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

2.  Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial.

Authors:  Roberto Contieri; Giovanni Lughezzani; Nicolò Maria Buffi; Gianluigi Taverna; Alessandro Giacobbe; Emanuele Micheli; Sabato Barra; Piergiuseppe Colombo; Elena Vanni; Giorgio Guazzoni; Massimo Lazzeri; Rodolfo Hurle
Journal:  Front Oncol       Date:  2022-05-18       Impact factor: 5.738

3.  Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis.

Authors:  Sruthi Babu; Nam W Kim; Maoxin Wu; Ina Chan; Luisa F Escobar-Hoyos; Kenneth R Shroyer
Journal:  Am J Clin Pathol       Date:  2021-10-13       Impact factor: 5.400

Review 4.  The Paris System for Reporting Urinary Cytology: A Meta-Analysis.

Authors:  Ilias P Nikas; Svenja Seide; Tanja Proctor; Zoi Kleinaki; Maria Kleinaki; Jordan P Reynolds
Journal:  J Pers Med       Date:  2022-01-27

5.  Accuracy of Paris 2016 System for Non-invasive Diagnosis Bladder Malignancy.

Authors:  Azadeh Rakhshan; Esmat Arvin; Sam Alahyari; Behrang Kazeminegad; Tahmineh Mollasharifi; Alireza Bagheri; Fereshteh Aliakbari; Seyed Jalil Hosseini; Mohammad Soleimani; Mahsa Ahadi; Elena Jamali; Afshin Moradi; Zahra Sadeghzadeh; Saleh Ghiasi; Malihe Nasiri; Farzad Allameh
Journal:  Iran J Pathol       Date:  2022-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.